| David Heath Stacey, MD | |
|
3721 South Champion Dr, Rogers, AR 72758-7275 | |
| (479) 571-3100 | |
| (479) 571-3101 |
| Full Name | David Heath Stacey |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 20 Years |
| Location | 3721 South Champion Dr, Rogers, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740245893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 48761 (Wisconsin) | Secondary |
| 2082S0099X | Plastic Surgery - Plastic Surgery Within The Head And Neck | E-6144 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center-springdale | Springdale, AR | Hospital |
| Entity Name | Sgoh Acquisition Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1568643005 PECOS PAC ID: 5092616276 Enrollment ID: O20081016000559 |
News Archive
Patients who are underweight or small in stature are twice as likely to experience complications or die during insertion of an implantable cardioverter-defibrillator (ICD) compared to obese and normal-weight patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
UCLA researchers and their partners across Los Angeles County have been awarded an $11 million grant to fund research on community-based interventions to reduce the higher rates of stroke and death from stroke among disadvantaged Hispanics, African Americans and Asian-Americans.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Results of clinical research on new presbyopia treatments now available in Europe-and possibly available soon in the United States-were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.
› Verified 9 days ago
| Entity Name | Northwest Arkansas Center For Plastic Surgery, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396057758 PECOS PAC ID: 5496888505 Enrollment ID: O20100726000901 |
News Archive
Patients who are underweight or small in stature are twice as likely to experience complications or die during insertion of an implantable cardioverter-defibrillator (ICD) compared to obese and normal-weight patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
UCLA researchers and their partners across Los Angeles County have been awarded an $11 million grant to fund research on community-based interventions to reduce the higher rates of stroke and death from stroke among disadvantaged Hispanics, African Americans and Asian-Americans.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Results of clinical research on new presbyopia treatments now available in Europe-and possibly available soon in the United States-were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Heath Stacey, MD 3721 South Champion Dr, Suite 210, Rogers, AR 72758-4999 Ph: (479) 571-3100 | David Heath Stacey, MD 3721 South Champion Dr, Rogers, AR 72758-7275 Ph: (479) 571-3100 |
News Archive
Patients who are underweight or small in stature are twice as likely to experience complications or die during insertion of an implantable cardioverter-defibrillator (ICD) compared to obese and normal-weight patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
UCLA researchers and their partners across Los Angeles County have been awarded an $11 million grant to fund research on community-based interventions to reduce the higher rates of stroke and death from stroke among disadvantaged Hispanics, African Americans and Asian-Americans.
In this study, researchers posing as parents sought specialty care for children in Cook County, Ill., to examine access opportunities for families on Medicaid. They found a major disparity between children with public insurance versus private insurance - 66 percent of the callers saying the children were insured by Medicaid were denied an appointment, compared to 11 percent with a private plan.
Results of clinical research on new presbyopia treatments now available in Europe-and possibly available soon in the United States-were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.
› Verified 9 days ago